Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
11 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
17-C-0037
Phase II Trial of LB100, a Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
Completed Study; data analyses ongoing
18-125 Years
NCI
Giant Astrocytoma
16-C-0081
A Phase I Dose Escalation Trial of Re-Irradiation in Good Prognosis Recurrent Glioblastoma
Completed Study; data analyses ongoing
18-125 Years
NCI
Giant Astrocytoma
001859-C
A Phase I Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
Recruitment has not started
18-120 Years
NCI
Astrocytoma
18-D-0114
An Open Label Pilot Study of Denosumab Treatment for Fibrous Dysplasia
Completed Study; data analyses ongoing
18-125 Years
NIDCR
Giant
18-C-0080
Feasibility and Preliminary Efficacy of an Enhanced Mindfulness Intervention for Children and Young Adults with High Grade or High-Risk Cancer and Their Caregivers: A Pilot Randomized Controlled Trial
Completed Study; data analyses ongoing
5-125 Years
NCI
Astrocytoma
17-C-0009
Phase I Trial of Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide (tmz) Followed by Randomized Phase II Trial of Zotiraciclib (TG02) plus Temozolomide versus Temozolomide alone in Adults with Recurrent Anaplastic Astrocytoma and Glioblastom
Completed Study; data analyses ongoing
18-125 Years
NCI
Astrocytoma
16-C-0151
Evaluation of the Natural History of and Specimen Banking for Patients with Tumors of the Central Nervous System
No longer recruiting/follow-up only
18-125 Years
NCI
Astrocytoma
15-N-0073
A Phase I Study of Intrathecal Administration of scAAV9/JeT-GAN for the Treatment of Giant Axonal Neuropathy
Participants currently recruited/enrolled
3-99 Years
NINDS
Giant
15-C-0093
Phase I Trial of TURALIO (pexidartinib, PLX3397) in Children and Young Adults with Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor (TGCT
Participants currently recruited/enrolled
3-35 Years
NCI
Giant
14-AR-0200
Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis
Participants currently recruited/enrolled
3-125 Years
NIAMS
Giant
00-HG-0153
Investigations into Chediak-Higashi Syndrome and Related Disorders
Participants currently recruited/enrolled
0-70 Years
NHGRI
Giant